History | Multimorbidity: clinical assessment and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Consultation comments published

Consultation comments and responses (PDF 2.36 MB)

Published:

21 September 2016

Draft guidance consultation

Draft guideline (PDF 4.34 MB)

Published:

17 May 2016
Short version of draft guideline (PDF 287 KB)

Published:

17 May 2016
Guideline appendices (PDF 10.29 MB)

Published:

17 May 2016
Comments form (MSWord 37 KB)

Published:

17 May 2016

Stakeholder list updated

Stakeholder list (PDF 43 KB)

Published:

28 April 2016
Stakeholder list (PDF 43 KB)

Published:

07 September 2016
Stakeholder list (PDF 44 KB)

Published:

20 September 2016

Committee list updated

Committee member list (PDF 92 KB)

Published:

11 April 2016
Committee member list (PDF 162 KB)

Published:

21 September 2016

Equality and health inequalities assessment

Equality impact assessment Section 3 (PDF 293 KB)

Published:

12 April 2016
Equality impact assessment 4 (PDF 160 KB)

Published:

01 August 2016

Pre-consultation documents released

Economic plan (MSWord 36 KB)

Published:

19 February 2016
Search strategies (MSWord 205 KB)

Published:

19 February 2016
Review questions (MSWord 16 KB)

Published:

19 February 2016

Committee meetings

Committee meeting
Minutes 5 (PDF 227 KB)

Published:

03 March 2016
Minutes 6 (PDF 129 KB)

Published:

03 March 2016
Minutes 7 (PDF 286 KB)

Published:

03 March 2016
Minutes 8 (PDF 287 KB)

Published:

03 March 2016
Minutes 9 (PDF 287 KB)

Published:

03 March 2016
Minutes 10 (PDF 292 KB)

Published:

03 March 2016
Minutes 11 (PDF 305 KB)

Published:

28 October 2016
Minutes 12 (PDF 290 KB)

Published:

28 October 2016

Multimorbidity: equality impact assessment scoping

Multimorbidity: equality impact assessment scoping
Multimorbidity: equality impact assessment scoping (PDF 144 KB)

Published:

07 January 2015

Multimorbidity: stakeholder workshop notes.

Multimorbidity: stakeholder workshop notes.
Multimorbidity: stakeholder workshop notes. (PDF 254 KB)

Published:

07 January 2015

Multimorbidity: GDG minutes

Multimorbidity: GDG minutes
Multimorbidity: GDG minutes 4
Multimorbidity: GDG minutes 4 (PDF 198 KB)

Published:

24 June 2015
Multimorbidity: GDG minutes 3
Multimorbidity: GDG minutes 3 (PDF 184 KB)

Published:

24 June 2015
Multimorbidity: GDG minutes 2
Multimorbidity: GDG minutes 2 (PDF 140 KB)

Published:

24 June 2015
Multimorbidity: GDG minutes 1
Multimorbidity: GDG minutes 1 (PDF 175 KB)

Published:

24 June 2015
Multimorbidity: GDG members list
Multimorbidity: GDG members list (PDF 62 KB)

Published:

12 November 2014

Multimorbidity: final scope

Multimorbidity: final scope
Multimorbidity: final scope (PDF 166 KB)

Published:

12 November 2014

Multimorbidity: scope comments table

Multimorbidity: scope comments table
Multimorbidity: scope comments table (PDF 1.03 MB)

Published:

12 November 2014

Multimorbidity: scope consultation

Multimorbidity: scope consultation information
Multimorbidity: scope consultation document
Multimorbidity: scope consultation document (PDF 170 KB)

Published:

06 August 2014

Multimorbidity: clinical assessment and management stakeholder list and how to register

Multimorbidities: clinical assessment and management - stakeholder list
Multimorbidities: clinical assessment and management - stakeholder list (PDF 12 KB)

Published:

30 July 2014